Rethinking Trial Access in Lower-Income Regions
Expanding breast cancer research leadership beyond high-income countries can be achieved through technology and mindset shifts, building more inclusive global trial networks.
Gen Li, PhD, MBA, president of Phesi, discussed the company's analysis on global inequity in breast cancer development in a recent video interview with Applied Clinical Trials.
- Geographic concentration of breast cancer trial leaders is in the US and China, with a positive outlook on global diversity.
- Operational barriers in lower-income countries are due to traditional business models.
- Opportunities exist to implement a more patient-centric approach using artificial intelligence (AI) and machine learning.
Identifying local leaders and redistributing trial workloads can improve recruitment by using AI to identify and activate new sites.
Author's summary: Technology can expand breast cancer research.